Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-Liang Ding

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Genetic Testing and Molecular Biomarkers|April 23, 2011
Mutation-sensitive molecular switch method to detect CES1A2 mutation in the Chinese Han and Yao populationsXiao-Liang Ding, Yang-Lin Deng, Jun Zhang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1-[(6-Chloro-3-pyrid-yl)meth-yl]-N-(4-ethoxy-phen-yl)-3-phenyl-1H-pyrazole-5-carboxamideZheng Tang, Xiao-Liang Ding, Wen-Liang Dong, et al.
Pharmacogenetics and Genomics|February 4, 2015
Reply to the comment from Bjerre et alXiao-Liang Ding, Zhi-Yao Chen, Cheng Xie, et al.
European Journal of Clinical Pharmacology|October 26, 2012
Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteersJing-Jing Zhang, Hua Zhang, Xiao-Liang Ding, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 2015
The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipientsJing-Jing Zhang, Shuai-Bing Liu, Ling Xue, et al.
The American Journal of the Medical Sciences|September 24, 2014
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patientsLing Xue, Wen-Wen Zhang, Xiao-Liang Ding, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 13, 2015
[Population pharmacokinetics and pharmacodynamics of clopidogrel in patients with acute coronary syndrome]Cheng Xie, Xiao-Liang Ding, Ling Xue, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2012
Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trialsXiao Liang Ding, Cheng Xie, Bin Jiang, et al.
Pharmaceutical Research|December 25, 2019
Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation PatientsLing Xue, Wen-Juan Zhang, Ji-Xin Tian, et al.
British Journal of Clinical Pharmacology|October 21, 2016
Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patientsLing Xue, Nick Holford, Xiao-Liang Ding, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Genetic Testing and Molecular Biomarkers|April 23, 2011
Mutation-sensitive molecular switch method to detect CES1A2 mutation in the Chinese Han and Yao populationsXiao-Liang Ding, Yang-Lin Deng, Jun Zhang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1-[(6-Chloro-3-pyrid-yl)meth-yl]-N-(4-ethoxy-phen-yl)-3-phenyl-1H-pyrazole-5-carboxamideZheng Tang, Xiao-Liang Ding, Wen-Liang Dong, et al.
Pharmacogenetics and Genomics|February 4, 2015
Reply to the comment from Bjerre et alXiao-Liang Ding, Zhi-Yao Chen, Cheng Xie, et al.
European Journal of Clinical Pharmacology|October 26, 2012
Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteersJing-Jing Zhang, Hua Zhang, Xiao-Liang Ding, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 2015
The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipientsJing-Jing Zhang, Shuai-Bing Liu, Ling Xue, et al.
The American Journal of the Medical Sciences|September 24, 2014
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patientsLing Xue, Wen-Wen Zhang, Xiao-Liang Ding, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 13, 2015
[Population pharmacokinetics and pharmacodynamics of clopidogrel in patients with acute coronary syndrome]Cheng Xie, Xiao-Liang Ding, Ling Xue, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2012
Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trialsXiao Liang Ding, Cheng Xie, Bin Jiang, et al.
Pharmaceutical Research|December 25, 2019
Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation PatientsLing Xue, Wen-Juan Zhang, Ji-Xin Tian, et al.
British Journal of Clinical Pharmacology|October 21, 2016
Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patientsLing Xue, Nick Holford, Xiao-Liang Ding, et al.
Pageof 2